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Abstract
Purpose: To evaluate percutaneous cholecystostomy in
patients with acute cholecystitis and an increased sur-
gical risk.
Methods: Thirty-three patients with acute cholecystitis
(calculous, n  22; acalculous, n  11) underwent per-
cutaneous cholecystostomy by means of a transhepatic
(n  21) or transperitoneal (n  12) access route. Clin-
ical and laboratory parameters were retrospectively
studied to determine the benefit from cholecystostomy.
Results: All procedures were technically successful.
Twenty-two (67%) patients improved clinically within
48 hr; showing a significant decrease in body temper-
ature (n  13), normalization of the white blood cell
count (n  3), or both (n  6). There were 6 (18%)
minor/moderate complications (transhepatic access, n
 3; transperitoneal access, n  3). Further treatment
for patients with calculous cholecystitis was cholecys-
tectomy (n  9) and percutaneous and endoscopic
stone removal (n  8). Further treatment for patients
with acalculous cholecystitis was cholecystectomy (n
 2) and gallbladder ablation (n  2). There were 4
deaths (12%) either in hospital or within 30 days of
drainage; none of the deaths was procedure-related.
Conclusions: Percutaneous cholecystostomy is a safe
and effective procedure for patients with acute chole-
cystitis. For most patients with acalculous cholecystitis
percutaneous cholecystostomy may be considered a de-
finitive therapy. In calculous disease this treatment is
often only temporizing and a definitive surgical, en-
doscopic, or radiologic treatment becomes necessary.
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During the past 10 years, percutaneous cholecystostomy
has been used to approach the gallbladder and biliary tree
for a variety of indications such as gallbladder drainage
in patients with cholecystitis [1–8], cholecystolithotomy
[7–9], gallstone dissolution [8, 10], gallbladder ablation
[8], drainage for obstructive jaundice [4, 7], and as a pro-
batory treatment in critically ill patients in intensive care
units with sepsis of unknown origin [11, 12].
Notwithstanding the value of percutaneous chole-
cystostomy for all the indications mentioned above, the
most important indication remains acute cholecystitis
in patients who are at high risk for cholecystectomy. In
these patients, percutaneous cholecystostomy can be
used to overcome a critical period or it can replace
cholecystectomy either alone or in combination with
other interventional radiological procedures.
This study was performed to evaluate the use of
percutaneous cholecystostomy in patients with sus-
pected acute cholecystitis and an increased surgical
risk. Special attention was given to the clinical perfor-
mance of the patient following drainage and to proce-
dure-related complications. The effect of different
drainage techniques, such as a transhepatic or a trans-
peritoneal approach, on the occurrence of complica-
tions was studied. In addition, the role of percutaneous
cholecystostomy in long-term treatment was assessed.
Materials and Methods
During the period January 1990 to July 1994, percutaneous chole-
cystostomy was attempted in 33 patients with suspected acute cho-
lecystitis. The patients (19 men and 14 women; 35–89 years, mean
age 65 years) were suspected of having acute cholecystitis because
of clinical, laboratory, and sonographic findings. Twenty-nine pa-
tients had right upper quadrant pain, 28 patients had a positive Mur-
phy’s sign, and in 11 patients a mass was palpated in the right upper
abdomen. Thirty patients had fever (body temperature 37.57C), 25
patients had elevated white blood cell (WBC) counts ( 10 1 109/l),
and 27 patients had increased serum bilirubin levels ( 14 mmol/l).
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Fig. 1. A A 64-year-old woman with perforation of the gallbladder
because of calculous cholecystitis. Cholecystography shows an irreg-
ularly defined lumen of the gallbladder and an impacted stone in the
cystic duct. B A pericholecystic fluid collection was drained sepa-
rately. Injection of contrast medium shows that this fluid collection
communicates with the gallbladder.
Fig. 2. A 71-year-old woman with a cholangiocarcinoma of the bil-
iary tree for which she had been treated with three self-expandable
endoprostheses 21 months previously. The patient developed acute
cholecystitis when the cystic duct became subtotally obstructed by
tumor growth. A small trail of contrast can be seen into one of the
stents. The gallbladder had to be drained with two catheters because
of a mucosal dissection which divided the lumen of the gallbladder
into two parts. At a later stage, ablation of the gallbladder through
both catheters was performed with ethanol 96%. Care was taken to
inject small amounts of ethanol in order to prevent overflow into the
biliary tree.
Fig. 3. A 60-year-old woman with calculous cholecystitis. The gallblad-
der was drained transperitoneally with a pigtail catheter. Cholecystochol-
angiography shows multiple stones in the gallbladder and a stone in the
distal common bile duct. Cholecystectomy was performed at a later stage.
The stone in the common bile duct was removed endoscopically.
Fig. 4. A An 80-year-old man with calculous cholecystitis. Chole-
cystocholangiography shows multiple stones in the gallbladder and
an impacted stone in the common bile duct. B Same patient as in A.
A dormia basket is introduced through the cystic duct into the com-
mon bile duct. The stone in the common bile duct was caught and
pushed into the duodenum. Subsequently, the stones in the gallblad-
der were removed percutaneously.
Findings at ultrasound examinations were an enlarged gallbladder
(transverse diameter ¢ 40 mm) in 31 patients, gallbladder wall thick-
ening (¢ 4 mm) in 33 patients, gallstones in 22 patients, and pericho-
lecystic fluid collections in 3 patients.
All 33 patients were considered to be poor candidates for chole-
cystectomy due to their general condition. Concomitant diseases in
these patients were cardiopulmonary disease (n  13), recent abdom-
inal surgery (n  8), malignancy (n  12), pancreatitis (n  3), mul-
titrauma (n  1), Addison’s disease (n  1), multiple sclerosis (n 
1), diabetes (n  1), renal insufficiency (n  1), and liver cirrhosis (n
 2). According to the American Society of Anesthesiologists’ (ASA)
Physical Status Classification [13], 8 patients were in class 2 (mild
systemic disease), 21 patients were in class 3 (severe systemic disease
that is not incapacitating), and 4 patients were in class 4 (incapacitating
systemic disease that is a constant threat to life).
Twenty-seven patients received continued or newly installed in-
travenous (iv) antibiotics (Augmentin) during cholecystostomy. Per-
cutaneous cholecystostomy was usually performed in a radiology
suite using both sonographic and fluoroscopic guidance. Six patients
were treated in the intensive care unit; in these patients only sono-
graphic guidance was used. The gallbladder was punctured with a
18–22 gauge needle under sonographic guidance using a transhepatic
approach in 21 patients and a transperitoneal approach in 12 patients.
By using either Seldinger (n  29) or trocar techniques (n  4), 7 Fr
balloon catheters (n  4) or 8–10 Fr pigtail catheters (n  29) (Cook,
Bjaeverskov, Denmark) were placed in the gallbladder. In addition,
in two of these patients pericholecystic fluid collections were sepa-
rately drained percutaneously with 10–12 Fr catheters (Fig. 1). Bile
was aspirated and cultured and a small amount of contrast material
was injected to confirm the location of the catheter. Injection of larger
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amounts of contrast material immediately after catheter placement
was avoided in order not to increase the pressure within the gall-
bladder. Diagnostic cholecystography to determine the presence of
gallstones and patency of the cystic and common bile duct was gen-
erally performed 1 week following cholecystostomy.
Patients’ hospital charts were reviewed retrospectively to assess
clinical improvement following cholecystostomy. Benefit from cho-
lecystostomy was determined by slightly modifying the criteria as
proposed by McGahan and Lindfors [6]. Clinical improvement was
considered present when there was either a 72-hr decrease in body
temperature ¡ 37.57C in patients with fever or a 72-hr decrease in
WBC¡ 101 109/l in patients with an elevated WBC. Complications
of percutaneous cholecystostomy and the further course and treat-
ment of patients, including in-hospital deaths, were also evaluated.
Results
Catheter placement was successful in all 33 patients.
Clinical improvement following cholecystostomy was
observed in 30 (91%) patients. Seventeen patients im-
proved after 24 hr, 5 patients improved after 48 hr and
8 patients improved after 1 week. A significant de-
crease in body temperature was observed in 28 of 30
(93%) patients with fever prior to cholecystostomy: in
13 patients after 24 hr, in 6 patients after 48 hr, and in
9 patients after 1 week. Normalization of WBC was
seen in 13 of 25 (52%) patients with an elevated WBC:
in 5 patients after 24 hr, in 4 patients after 48 hr, and
in 4 patients after 1 week. Following cholecystostomy,
relief of right upper quadrant pain was observed in 17
patients after 24 hr, in 7 patients after 48 hr, in 2 pa-
tients after 3 days and in 1 patient after 4 days.
Bile cultures were positive for organisms in 24 pa-
tients. Either Escherichia coli and/or Klebsiella sp. were
found in 19 of these 24 cultures. Cultures were negative
in seven patients and had been neglected in two patients.
For those seven patients with negative bile cultures, clin-
ical improvement following cholecystostomy was ob-
served after 24 hr in three patients, after 48 hr in two
patients and after 1 week in one patient. The remaining
patient did not improve clinically. Of those eight patients
who showed clinical improvement only after 1 week of
drainage, bile cultures were positive in six.
Procedure-related complications were observed in 6
of 33 (18%) patients. Three early ( 48 hr) complica-
tions were seen in patients in whom the gallbladder had
been drained transhepatically. Pericatheter bleeding was
observed in 1 patient with a bleeding disorder and could
be treated conservatively. One patient developed sepsis
following cholecystostomy and was successfully treated
with i.v. antibiotics; this patient had not received i.v.
antibiotics during the procedure. In 1 patient the catheter
dislodged 1 day following cholecystostomy. Because
bile leakage did not occur and the clinical condition had
improved, reinsertion of the drain was not considered
necessary even though bile cultures grew Klebsiella sp.
One early complication was observed in a patient who
had been drained transperitoneally. In this patient the
lumen of the gallbladder was divided into two compart-
ments by a mucosal dissection. It was not recognized
initially but was noticed at sonographic reexamination
when symptoms of cholecystitis persisted. A second
catheter was inserted, after which the patient improved
clinically (Fig. 2).
Late complications were seen in 2 patients who
were drained transperitoneally. These patients devel-
oped recurrent cholecystitis when the drain was re-
moved intentionally after 21 and 37 days of drainage
respectively. In both patients relief was obtained by
placing a new drain in the gallbladder. Both patients
underwent cholecystectomy at a later stage. Duration
of gallbladder drainage ranged from 1 to 180 days
(mean 29 days).
Twenty-two patients had gallstones on cholecys-
tograms and/or ultrasound scans. Further course and
treatment in these patients with calculous cholecystitis
was as follows. One patient died 11 days following
cholecystostomy due to an aspiration pneumonia. An-
other patient died of liver failure 30 days after drainage.
Nine patients underwent cholecystectomy after 2–
180 days. In one of these patients cholecystectomy was
performed after unsuccessful percutaneous gallstone
dissolution therapy with methyl tert-butyl ether
(MTBE). Another patient underwent cholecystectomy
when percutaneous and endoscopic attempts to remove
an impacted stone in the cystic duct failed. In addition
to cholecystectomy, one patient underwent endoscopic
removal of common bile duct stones (Fig. 3). One of
nine patients who underwent cholecystectomy died
postoperatively due to a myocardial infarction.
Cholecystectomy was not performed in 11 patients.
Six of 11 patients underwent percutaneous stone re-
moval for gallbladder stones (n  2), gallbladder and
cystic duct stones (n  1), gallbladder and common bile
duct stones (n  1) (Fig. 4), cystic duct and common
bile duct stones (n  1) and common bile duct stones
alone (n  1). Three of 6 patients also underwent en-
doscopic stone removal for common bile duct stones
either alone (n  2) or in combination with cystic duct
stones (n  1). In 2 of 11 patients without cholecystec-
tomy, endoscopic stone removal of common bile duct
stones was the only further treatment. Three patients did
not receive further treatment. In 1 patient the drain dis-
lodged 1 day after cholecystostomy and was not re-
placed. In another patient with an inoperable
cholangiocarcinoma further treatment was considered
not to be indicated; this patient was sent home and she
died 2 months later with the gallbladder drain in situ. In
the third patient the gallbladder drain was removed after
32 days when she was referred to a nursing home.
Eleven patients did not have gallstones on chole-
cystography and/or ultrasound scans. Further course
and treatment in these patients with acalculous chole-
cystitis was as follows. One patient died 14 days after
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drainage due to a necrotizing pancreatitis. Two patients
underwent cholecystectomy, 25 and 30 days after cho-
lecystostomy, because elevated WBCs and other ab-
normal results of laboratory tests persisted.
Two patients with inoperable cholangiocarcinoma
and obstruction of the cystic duct underwent successful
gallbladder ablation with ethanol 96% (Fig. 2). Mu-
coceles or mucous fistulas were not observed. Six pa-
tients without obstruction of the cystic and common
bile ducts on diagnostic cholecystocholangiograms did
not receive any further treatment; their drains were re-
moved after 10–31 days (mean 22 days). None of these
patients developed recurrent cholecystitis after the
drain was removed.
Discussion
This study confirms the effectiveness of percutaneous
cholecystostomy for the treatment of patients with
acute cholecystitis. More than 90% of the patients in
our series improved clinically after gallbladder drain-
age, which is consistent with the results in several pre-
vious reports [3, 4, 7].
Lower (35–59%) [5, 6, 11, 12] clinical response
rates after percutaneous cholecystostomy in other series
can be explained by the fact that different groups of
patients are involved in these reports. Boland et al. [12],
for example, performed percutaneous cholecystostomy
for diagnostic and therapeutic purposes in patients with
unexplained sepsis in whom acute cholecystitis could
not be excluded. Thus, the proportion of patients who
eventually had acute cholecystitis is lower in their se-
ries, as illustrated by the lower number of patients with
a positive Murphy’s sign (23%) and the low number of
positive bile cultures (16%). The low clinical success
rate reported by Teplick et al. [5] can probably be ex-
plained by the advanced and very poor general condi-
tion of their patients, as reflected by the high number
of patients with prolonged sepsis of more than 2 weeks’
duration (25%) or pericholecystic fluid collections
(25%) indicating gallbladder wall necrosis. It also ex-
plains the high overall mortality rate (67%) in their
series compared with others [5, 14].
The majority of patients in our series improved
clinically within 48 hr, but in some patients improve-
ment was seen only after 1 week of drainage. The crit-
icism may be made that acute cholecystitis is unlikely
in those patients who show clinical improvement only
after 1 week of drainage. However, we observed a high
number of positive bile cultures in these patients and
the bacteria that were found did not suggest false pos-
itive cultures due to skin contamination [10, 15].
The numbers of positive bile cultures in our series
correlate well with those reported by Klimberg et al.
[3]. It has been suggested that the lower numbers of
positive bile cultures reported by McGahan and Lind-
fors [15] may be due to the prolonged use of broad-
spectrum antibiotics [10].
Similar to the reports by others, we found proce-
dure-related complications rare in patients undergoing
percutaneous cholecystostomy [1–4, 6–12]. Only one
moderately serious complication was observed in our
series; the sepsis in this patient might have been pre-
vented by using i.v. antibiotics during the procedure.
Although the benefit of i.v. antibiotics has never been
proven for percutaneous cholecystostomy we now rou-
tinely employ antibiotics for this procedure, according
to generally accepted practice [1, 3, 4, 8, 12]. The other
three early complications in our series can be con-
sidered ‘‘minor’’. Mild bleeding was observed in one
patient but major bleeding from percutaneous chole-
cystostomy has been reported, which stresses the im-
portance of correcting bleeding disorders [8]. There
was no difference in the complication rate between
those patients who were drained transhepatically and
those who were drained transperitoneally in our series.
Several authors have recommended a transhepatic ap-
proach and have suggested puncturing the upper third
of the gallbladder near its attachment to the liver in
order to reduce the risk of bile leakage [1, 4, 10]. Not-
withstanding these theoretical advantages of the trans-
hepatic approach, it has never been proved to be safer
than a transperitoneal approach.
In patients with an enlarged gallbladder that reaches
the anterior abdominal wall a transperitoneal approach
is technically easier because of the short distance be-
tween the skin and the gallbladder and the lack of an-
gulation by which the gallbladder is reached.
Warren et al. [16] in their review of a 100 abdom-
inal CT scans reported that in only 17% of patients was
there no interposition of liver or colon between the skin
and the gallbladder fundus [16]. However, in patients
with acute cholecystitis the cystic duct is obstructed,
the gallbladder will enlarge and the fundus of the gall-
bladder will reach the anterior abdominal wall in a sig-
nificant number of patients. Although the exact number
of patients in whom the gallbladder fundus reached the
anterior abdominal wall cannot be assessed from our
series, it enabled a transperitoneal approach in at least
one third of patients. Probably this number is even
higher because a transhepatic approach was preferen-
tially used in the initial period of the study.
It is our opinion that a transperitoneal approach
should be considered in patients who are treated in inten-
sive care units without fluoroscopic guidance and in pa-
tients in whom eventual percutaneous removal of
gallstones is foreseen. The presence of interposing bowel
or liver can of course be ruled out with ultrasound.
The Seldinger method proved to be a safe technique
for catheter placement in our series. Bile leakage, the-
oretically a potential disadvantage of this technique
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compared with the trocar technique, did not occur [10].
The main advantage of the Seldinger method remains
the use of an initial thin needle. Two patients developed
recurrent cholecystitis when the gallbladder drain was
removed intentionally prior to cholecystectomy. Both
patients had a stone in the cystic duct; however, be-
cause uninhibited flow of contrast through the cystic
duct and common bile duct to the duodenum was ob-
served on cholecystocholangiograms the drains were
removed. In order to avoid such recurrences we now
leave catheters in situ until the operation.
Because of the risk of recurrent disease, definitive
treatment for gallstones has been advocated for patients
who have had cholecystostomy for acute calculous cho-
lecystitis [17, 18]. In 30% of the patients in our series
who required such treatment, percutaneous cholecys-
tostomy provided adequate access to the gallbladder
and biliary tree for stone removal (Fig. 4). By adding
endoscopic retrograde cholangiopancreatography, an-
other 10% of patients could be successfully treated with
nonsurgical options. In addition, 15% of patients with
calculous cholecystitis did not receive definitive treat-
ment for their gallstones. One of these patients with a
malignant tumor who was in very poor general condi-
tion underwent long-term catheter drainage as de-
scribed by Boland et al. [18]. In two other patients the
drain was removed—intentionally in one patient and
unintentionally in the other. These patients did not de-
velop recurrent cholecystitis during their follow-up pe-
riod of 22 and 46 months, respectively. Therefore, in
patients with limited life expectancy who have had
acute calculous cholecystitis, removal of the drain may
be preferable to long-term catheter drainage when the
cystic and common bile ducts are patent without stones,
in order to avoid side effects such as skin inflammation,
biliary leakage, and pain.
In the majority of patients with acute acalculous
cholecystitis, percutaneous cholecystostomy provided
both the initial and the definitive treatment. Cholecys-
tectomy was generally not required. When the patient’s
clinical condition improved and the cystic duct and
common bile duct were patent on cholecystocholangio-
grams, the gallbladder drain was removed. In patients
with acalculous cholecystitis in whom the cystic duct
has become occluded by tumor growth there is the po-
tential risk of recurrent cholecystitis when the gallblad-
der drain is removed. In these patients ablation of the
gallbladder wall mucosa with ethanol and subsequent
removal of the gallbladder drain is an alternative to
long-term catheter drainage (Fig. 2).
In conclusion, percutaneous cholecystostomy is an
effective procedure for treatment of patients with acute
cholecystitis who are at high risk for cholecystectomy.
Clinical improvement is achieved in more than 90% of
patients, usually within 48 hr, but sometimes after a
delay of up to 1 week. Procedure-related complications
are rare and do not seem to relate to the access route
(transhepatic vs transperitoneal) to the gallbladder. In
a significant number of patients with calculous chole-
cystitis, definitive treatment of gallstones can be
achieved by a combination of percutaneous and endo-
scopic techniques. For some patients with cholecystitis,
especially those with acalculous cholecystis, percuta-
neous cholecystostomy offers both the initial and the
definitive treatment.
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